DOI: 10.1055/s-00023610

Drug Research

Referenz

Rosenstock J, Sankoh S, List JF.
Glucose-lowering activity of the dipeptidyl peptidase- 4 inhibitor saxagliptin in drug-naive patients with type 2 diabetes.

Diabetes Obes Metab 2008;
10: 376-386

Bibliographische Angaben herunterladen

Suchen in:
Aufrufen in: